Post by
Noteable on May 18, 2023 11:14am
Immunomedics former CFO pleads guilty to insider trading
May 18, 2023 - Former Immunomedics Chief Financial Officer Usama Malik has pleaded guilty to a charge of insider trading for tipping off his girlfriend that the biotech’s breast cancer drug had succeeded in a clinical trial, allowing her time to purchase shares before the information went public.
Immunomedics was acquired by Gilead in October 2020 for $21 billion.
https://www.fiercebiotech.com/biotech/former-immunomedics-cfo-pleads-guilty-securities-fraud-over-trodelvy-tip
Comment by
fasttrack5 on May 18, 2023 1:40pm
Let's hope ONC gets bought out for 21 billion also but without insider nonsense.
Comment by
westcoast1000 on May 18, 2023 3:22pm
That was very stupid of Usama Malik. He would have had more than enough for both of them from his options. Dumb dumb dumb.